| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 1.62e-04 | 43 | 9 | 2 | GO:0001965 | |
| GeneOntologyMolecularFunction | GTPase activity | 9.67e-03 | 341 | 9 | 2 | GO:0003924 | |
| GeneOntologyMolecularFunction | GTP binding | 1.29e-02 | 397 | 9 | 2 | GO:0005525 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 1.57e-02 | 439 | 9 | 2 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 1.57e-02 | 439 | 9 | 2 | GO:0019001 | |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 5.63e-07 | 40 | 9 | 3 | GO:0045762 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclase activity | 9.84e-07 | 48 | 9 | 3 | GO:0031281 | |
| GeneOntologyBiologicalProcess | positive regulation of lyase activity | 1.05e-06 | 49 | 9 | 3 | GO:0051349 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 1.84e-06 | 59 | 9 | 3 | GO:0045761 | |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 2.97e-06 | 69 | 9 | 3 | GO:0031279 | |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 3.52e-06 | 73 | 9 | 3 | GO:0051339 | |
| GeneOntologyBiologicalProcess | peptide hormone secretion | 7.98e-06 | 334 | 9 | 4 | GO:0030072 | |
| GeneOntologyBiologicalProcess | peptide secretion | 8.86e-06 | 343 | 9 | 4 | GO:0002790 | |
| GeneOntologyBiologicalProcess | regulation of hormone secretion | 1.02e-05 | 355 | 9 | 4 | GO:0046883 | |
| GeneOntologyBiologicalProcess | peptide transport | 1.02e-05 | 355 | 9 | 4 | GO:0015833 | |
| GeneOntologyBiologicalProcess | positive regulation of insulin secretion | 1.57e-05 | 120 | 9 | 3 | GO:0032024 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion by cell | 1.69e-05 | 404 | 9 | 4 | GO:1903532 | |
| GeneOntologyBiologicalProcess | amide transport | 1.97e-05 | 420 | 9 | 4 | GO:0042886 | |
| GeneOntologyBiologicalProcess | hormone secretion | 1.97e-05 | 420 | 9 | 4 | GO:0046879 | |
| GeneOntologyBiologicalProcess | hormone transport | 2.20e-05 | 432 | 9 | 4 | GO:0009914 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion | 2.26e-05 | 435 | 9 | 4 | GO:0051047 | |
| GeneOntologyBiologicalProcess | positive regulation of peptide hormone secretion | 3.51e-05 | 157 | 9 | 3 | GO:0090277 | |
| GeneOntologyBiologicalProcess | positive regulation of peptide secretion | 3.79e-05 | 161 | 9 | 3 | GO:0002793 | |
| GeneOntologyBiologicalProcess | positive regulation of protein secretion | 6.60e-05 | 194 | 9 | 3 | GO:0050714 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone secretion | 7.78e-05 | 205 | 9 | 3 | GO:0046887 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 8.87e-05 | 33 | 9 | 2 | GO:2000252 | |
| GeneOntologyBiologicalProcess | activation of adenylate cyclase activity | 9.43e-05 | 34 | 9 | 2 | GO:0007190 | |
| GeneOntologyBiologicalProcess | signal release | 1.10e-04 | 653 | 9 | 4 | GO:0023061 | |
| GeneOntologyBiologicalProcess | regulation of insulin secretion | 1.11e-04 | 231 | 9 | 3 | GO:0050796 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 1.32e-04 | 684 | 9 | 4 | GO:0010817 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 1.66e-04 | 45 | 9 | 2 | GO:0048521 | |
| GeneOntologyBiologicalProcess | regulation of system process | 1.74e-04 | 734 | 9 | 4 | GO:0044057 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | 1.79e-04 | 740 | 9 | 4 | GO:1903530 | |
| GeneOntologyBiologicalProcess | insulin secretion | 1.84e-04 | 274 | 9 | 3 | GO:0030073 | |
| GeneOntologyBiologicalProcess | regulation of peptide hormone secretion | 1.90e-04 | 277 | 9 | 3 | GO:0090276 | |
| GeneOntologyBiologicalProcess | regulation of peptide transport | 2.00e-04 | 282 | 9 | 3 | GO:0090087 | |
| GeneOntologyBiologicalProcess | regulation of peptide secretion | 2.00e-04 | 282 | 9 | 3 | GO:0002791 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 2.08e-04 | 286 | 9 | 3 | GO:0007188 | |
| GeneOntologyBiologicalProcess | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 2.13e-04 | 51 | 9 | 2 | GO:0035774 | |
| GeneOntologyBiologicalProcess | embryonic cranial skeleton morphogenesis | 2.22e-04 | 52 | 9 | 2 | GO:0048701 | |
| GeneOntologyBiologicalProcess | regulation of secretion | 2.43e-04 | 801 | 9 | 4 | GO:0051046 | |
| GeneOntologyBiologicalProcess | positive regulation of protein transport | 2.87e-04 | 319 | 9 | 3 | GO:0051222 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 3.06e-04 | 61 | 9 | 2 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of endocrine process | 3.06e-04 | 61 | 9 | 2 | GO:0044060 | |
| GeneOntologyBiologicalProcess | connective tissue development | 3.55e-04 | 343 | 9 | 3 | GO:0061448 | |
| GeneOntologyBiologicalProcess | regulation of protein secretion | 3.77e-04 | 350 | 9 | 3 | GO:0050708 | |
| GeneOntologyBiologicalProcess | endocrine hormone secretion | 4.87e-04 | 77 | 9 | 2 | GO:0060986 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | 5.70e-04 | 403 | 9 | 3 | GO:1904951 | |
| GeneOntologyBiologicalProcess | cranial skeletal system development | 5.79e-04 | 84 | 9 | 2 | GO:1904888 | |
| GeneOntologyBiologicalProcess | regulation of insulin secretion involved in cellular response to glucose stimulus | 6.94e-04 | 92 | 9 | 2 | GO:0061178 | |
| GeneOntologyBiologicalProcess | regulation of multicellular organism growth | 7.09e-04 | 93 | 9 | 2 | GO:0040014 | |
| GeneOntologyBiologicalProcess | secretion by cell | 7.20e-04 | 1064 | 9 | 4 | GO:0032940 | |
| GeneOntologyBiologicalProcess | positive regulation of transport | 7.65e-04 | 1081 | 9 | 4 | GO:0051050 | |
| GeneOntologyBiologicalProcess | insulin secretion involved in cellular response to glucose stimulus | 8.52e-04 | 102 | 9 | 2 | GO:0035773 | |
| GeneOntologyBiologicalProcess | protein secretion | 9.48e-04 | 480 | 9 | 3 | GO:0009306 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to extracellular region | 9.65e-04 | 483 | 9 | 3 | GO:0035592 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system morphogenesis | 9.72e-04 | 109 | 9 | 2 | GO:0048704 | |
| GeneOntologyBiologicalProcess | export from cell | 9.76e-04 | 1153 | 9 | 4 | GO:0140352 | |
| GeneOntologyBiologicalProcess | protein localization to extracellular region | 1.01e-03 | 490 | 9 | 3 | GO:0071692 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 1.02e-03 | 493 | 9 | 3 | GO:0010959 | |
| GeneOntologyBiologicalProcess | secretion | 1.21e-03 | 1221 | 9 | 4 | GO:0046903 | |
| GeneOntologyBiologicalProcess | endocrine process | 1.24e-03 | 123 | 9 | 2 | GO:0050886 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 1.34e-03 | 128 | 9 | 2 | GO:0050795 | |
| GeneOntologyBiologicalProcess | regulation of protein transport | 1.48e-03 | 560 | 9 | 3 | GO:0051223 | |
| GeneOntologyBiologicalProcess | ossification | 1.50e-03 | 562 | 9 | 3 | GO:0001503 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 1.61e-03 | 577 | 9 | 3 | GO:0043269 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | 1.73e-03 | 591 | 9 | 3 | GO:1903829 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system development | 1.78e-03 | 148 | 9 | 2 | GO:0048706 | |
| GeneOntologyBiologicalProcess | skeletal system development | 1.94e-03 | 615 | 9 | 3 | GO:0001501 | |
| GeneOntologyBiologicalProcess | feeding behavior | 2.13e-03 | 162 | 9 | 2 | GO:0007631 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | 2.30e-03 | 1450 | 9 | 4 | GO:1901701 | |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | 2.52e-03 | 674 | 9 | 3 | GO:0070201 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | 2.53e-03 | 1488 | 9 | 4 | GO:0051241 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 2.94e-03 | 191 | 9 | 2 | GO:0007189 | |
| GeneOntologyBiologicalProcess | cellular response to glucose stimulus | 3.10e-03 | 196 | 9 | 2 | GO:0071333 | |
| GeneOntologyBiologicalProcess | temperature homeostasis | 3.10e-03 | 196 | 9 | 2 | GO:0001659 | |
| GeneOntologyBiologicalProcess | cellular response to hexose stimulus | 3.19e-03 | 199 | 9 | 2 | GO:0071331 | |
| GeneOntologyBiologicalProcess | cellular response to monosaccharide stimulus | 3.25e-03 | 201 | 9 | 2 | GO:0071326 | |
| GeneOntologyBiologicalProcess | cellular response to carbohydrate stimulus | 3.71e-03 | 215 | 9 | 2 | GO:0071322 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport | 3.81e-03 | 218 | 9 | 2 | GO:1903169 | |
| GeneOntologyBiologicalProcess | intracellular glucose homeostasis | 3.81e-03 | 218 | 9 | 2 | GO:0001678 | |
| GeneOntologyCellularComponent | apical part of cell | 1.67e-03 | 592 | 9 | 3 | GO:0045177 | |
| GeneOntologyCellularComponent | sarcolemma | 2.84e-03 | 190 | 9 | 2 | GO:0042383 | |
| GeneOntologyCellularComponent | neuronal cell body | 4.45e-03 | 835 | 9 | 3 | GO:0043025 | |
| GeneOntologyCellularComponent | dendrite | 4.81e-03 | 858 | 9 | 3 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 4.84e-03 | 860 | 9 | 3 | GO:0097447 | |
| GeneOntologyCellularComponent | cell body | 6.01e-03 | 929 | 9 | 3 | GO:0044297 | |
| HumanPheno | Adrenal hyperplasia | 6.92e-05 | 25 | 3 | 2 | HP:0008221 | |
| HumanPheno | Increased circulating aldosterone concentration | 1.14e-04 | 32 | 3 | 2 | HP:0000859 | |
| HumanPheno | Abnormal circulating renin concentration | 1.22e-04 | 33 | 3 | 2 | HP:0040084 | |
| HumanPheno | Abnormality of aldosterone production | 2.18e-04 | 44 | 3 | 2 | HP:0002855 | |
| HumanPheno | Abnormal circulating aldosterone concentration | 2.93e-04 | 51 | 3 | 2 | HP:0040085 | |
| HumanPheno | Abnormality of renin-angiotensin system | 3.41e-04 | 55 | 3 | 2 | HP:0000847 | |
| HumanPheno | Adrenal overactivity | 3.41e-04 | 55 | 3 | 2 | HP:0002717 | |
| HumanPheno | Adrenocortical abnormality | 6.70e-04 | 77 | 3 | 2 | HP:0000849 | |
| HumanPheno | Abnormal EKG | 2.09e-03 | 136 | 3 | 2 | HP:0003115 | |
| HumanPheno | Nephrolithiasis | 2.34e-03 | 144 | 3 | 2 | HP:0000787 | |
| HumanPheno | Abnormal adrenal morphology | 2.37e-03 | 145 | 3 | 2 | HP:0011732 | |
| HumanPheno | Abnormal endocrine morphology | 2.37e-03 | 145 | 3 | 2 | HP:0031071 | |
| HumanPheno | Abnormality of adrenal physiology | 2.50e-03 | 149 | 3 | 2 | HP:0011733 | |
| HumanPheno | Athetosis | 3.10e-03 | 166 | 3 | 2 | HP:0002305 | |
| MousePheno | abnormal urine catecholamine level | 7.73e-06 | 9 | 7 | 2 | MP:0011478 | |
| MousePheno | increased oxygen consumption | 2.16e-05 | 121 | 7 | 3 | MP:0005289 | |
| MousePheno | decreased circulating hormone level | 7.60e-05 | 551 | 7 | 4 | MP:0014457 | |
| MousePheno | increased basal metabolism | 8.07e-05 | 28 | 7 | 2 | MP:0008965 | |
| MousePheno | abnormal oxygen consumption | 8.98e-05 | 195 | 7 | 3 | MP:0005288 | |
| MousePheno | abnormal alcohol consumption | 1.27e-04 | 35 | 7 | 2 | MP:0001425 | |
| MousePheno | decreased hormone level | 1.32e-04 | 635 | 7 | 4 | MP:0014455 | |
| MousePheno | increased carbon dioxide production | 1.50e-04 | 38 | 7 | 2 | MP:0008963 | |
| MousePheno | decreased circulating insulin level | 1.62e-04 | 238 | 7 | 3 | MP:0002727 | |
| MousePheno | abnormal circulating glucagon level | 1.66e-04 | 40 | 7 | 2 | MP:0002695 | |
| MousePheno | abnormal basal metabolism | 2.30e-04 | 47 | 7 | 2 | MP:0008961 | |
| MousePheno | abnormal carbon dioxide production | 4.68e-04 | 67 | 7 | 2 | MP:0008962 | |
| MousePheno | abnormal circulating hormone level | 6.38e-04 | 954 | 7 | 4 | MP:0005418 | |
| MousePheno | decreased percent body fat/body weight | 7.35e-04 | 84 | 7 | 2 | MP:0005459 | |
| MousePheno | abnormal respiratory function | 7.42e-04 | 399 | 7 | 3 | MP:0002327 | |
| MousePheno | abnormal hormone level | 1.00e-03 | 1073 | 7 | 4 | MP:0003953 | |
| MousePheno | abnormal food intake | 1.28e-03 | 481 | 7 | 3 | MP:0005449 | |
| MousePheno | decreased circulating leptin level | 1.44e-03 | 118 | 7 | 2 | MP:0005668 | |
| MousePheno | abnormal circulating insulin level | 1.47e-03 | 505 | 7 | 3 | MP:0001560 | |
| MousePheno | increased circulating leptin level | 1.62e-03 | 125 | 7 | 2 | MP:0005669 | |
| MousePheno | abnormal catecholamine level | 2.08e-03 | 142 | 7 | 2 | MP:0011479 | |
| MousePheno | abnormal percent body fat/body weight | 2.14e-03 | 144 | 7 | 2 | MP:0005457 | |
| MousePheno | abnormal respiration | 2.40e-03 | 598 | 7 | 3 | MP:0001943 | |
| MousePheno | abnormal gas homeostasis | 2.42e-03 | 600 | 7 | 3 | MP:0003948 | |
| MousePheno | abnormal eating behavior | 2.47e-03 | 604 | 7 | 3 | MP:0001431 | |
| MousePheno | abnormal drinking behavior | 2.60e-03 | 159 | 7 | 2 | MP:0001422 | |
| MousePheno | abnormal triglyceride level | 2.90e-03 | 639 | 7 | 3 | MP:0000187 | |
| MousePheno | increased insulin sensitivity | 3.61e-03 | 188 | 7 | 2 | MP:0002891 | |
| MousePheno | increased food intake | 3.65e-03 | 189 | 7 | 2 | MP:0011939 | |
| MousePheno | abnormal consumption behavior | 3.68e-03 | 695 | 7 | 3 | MP:0002069 | |
| MousePheno | respiratory distress | 4.24e-03 | 204 | 7 | 2 | MP:0001954 | |
| MousePheno | abnormal glucose tolerance | 5.24e-03 | 787 | 7 | 3 | MP:0005291 | |
| MousePheno | abnormal circulating leptin level | 5.64e-03 | 236 | 7 | 2 | MP:0005667 | |
| MousePheno | abnormal fat cell morphology | 5.92e-03 | 242 | 7 | 2 | MP:0009115 | |
| MousePheno | abnormal abdominal fat pad morphology | 6.91e-03 | 262 | 7 | 2 | MP:0000010 | |
| MousePheno | increased circulating triglyceride level | 6.91e-03 | 262 | 7 | 2 | MP:0001552 | |
| MousePheno | abnormal respiratory system physiology | 7.58e-03 | 897 | 7 | 3 | MP:0002133 | |
| Domain | - | 4.45e-03 | 746 | 9 | 3 | 3.40.50.300 | |
| Domain | P-loop_NTPase | 6.38e-03 | 848 | 9 | 3 | IPR027417 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 7.38e-05 | 27 | 7 | 2 | M47518 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 3.69e-04 | 60 | 7 | 2 | MM14964 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 3.81e-04 | 61 | 7 | 2 | MM15071 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 5.02e-04 | 70 | 7 | 2 | M8232 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 5.31e-04 | 72 | 7 | 2 | MM14631 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 6.23e-04 | 78 | 7 | 2 | M1921 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 8.29e-04 | 90 | 7 | 2 | M835 | |
| Pathway | WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING | 8.66e-04 | 92 | 7 | 2 | M39441 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 9.04e-04 | 94 | 7 | 2 | M797 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.04e-03 | 101 | 7 | 2 | M1979 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.19e-03 | 108 | 7 | 2 | M17034 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 1.35e-03 | 115 | 7 | 2 | M9387 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 2.08e-03 | 143 | 7 | 2 | MM15055 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.19e-03 | 147 | 7 | 2 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.31e-03 | 151 | 7 | 2 | M39329 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 2.40e-03 | 154 | 7 | 2 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 2.46e-03 | 156 | 7 | 2 | M39475 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 2.50e-03 | 157 | 7 | 2 | M4904 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.19e-03 | 178 | 7 | 2 | M2890 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 1.76e-02 | 430 | 7 | 2 | MM15160 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 2.03e-02 | 463 | 7 | 2 | M507 | |
| Pubmed | 8.92e-07 | 6 | 9 | 2 | 10598591 | ||
| Pubmed | 1.42e-04 | 70 | 9 | 2 | 12036966 | ||
| Pubmed | 1.58e-04 | 438 | 9 | 3 | 32628020 | ||
| Interaction | CRHR1 interactions | 3.71e-05 | 21 | 9 | 2 | int:CRHR1 | |
| ToppCell | droplet-Kidney-nan-18m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 157 | 8 | 2 | eb64a4e89843895d16015c7d51805f164ed7ea5b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.38e-04 | 158 | 8 | 2 | 35f3082109a5930b89d14db3c8fa93148d3a5dd4 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.73e-04 | 166 | 8 | 2 | 49103b75c3e08656c5774f56fd00d7bd53eefcfb | |
| ToppCell | Ionocyte|World / Class top | 3.92e-04 | 170 | 8 | 2 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 | |
| ToppCell | Ionocyte-iono-2|World / Class top | 4.05e-04 | 173 | 8 | 2 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-04 | 174 | 8 | 2 | f230d23618a6487f2664efb2c677e0a4559e2bf4 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 175 | 8 | 2 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 183 | 8 | 2 | 7534587fa35837c0aaca93c542f2eee493eba637 | |
| ToppCell | P03|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.63e-04 | 185 | 8 | 2 | a07dbe1f76e40734a28826423a5cc64b8e56af5e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 4.78e-04 | 188 | 8 | 2 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-04 | 193 | 8 | 2 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| Computational | Genes in the cancer module 87. | 2.43e-04 | 44 | 6 | 2 | MODULE_87 | |
| Drug | bromododecanol | 2.05e-05 | 20 | 8 | 2 | CID000137895 | |
| Drug | AC1L1KS5 | 1.66e-04 | 334 | 8 | 3 | CID000005631 | |
| Drug | AC1MBZ1C | 2.56e-04 | 387 | 8 | 3 | CID000003541 | |
| Drug | AC1L1AU5 | 2.96e-04 | 75 | 8 | 2 | CID000001149 | |
| Drug | AC1L1HXY | 2.96e-04 | 75 | 8 | 2 | CID000004340 | |
| Drug | fructosamine | 5.47e-04 | 102 | 8 | 2 | CID000020484 | |
| Drug | Pl-cs | 6.01e-04 | 107 | 8 | 2 | CID006450086 | |
| Drug | Pentobarbital | 6.94e-04 | 115 | 8 | 2 | ctd:D010424 | |
| Drug | Evans blue dye | 8.46e-04 | 127 | 8 | 2 | CID005356750 | |
| Drug | GTP[S] | 8.84e-04 | 591 | 8 | 3 | CID000001764 | |
| Drug | formalin | 1.07e-03 | 143 | 8 | 2 | CID000000712 | |
| Drug | N-methyl-DL-aspartic acid | 1.19e-03 | 655 | 8 | 3 | CID000004376 | |
| Drug | Norepinephrine | 1.52e-03 | 171 | 8 | 2 | ctd:D009638 | |
| Drug | PNU-107859 | 1.58e-03 | 174 | 8 | 2 | CID004369084 | |
| Drug | metyrapone | 1.67e-03 | 179 | 8 | 2 | CID000004174 | |
| Drug | Triflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.84e-03 | 188 | 8 | 2 | 7466_UP | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 1.92e-03 | 192 | 8 | 2 | 3400_DN | |
| Drug | Iopromide [73334-07-3]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 3481_UP | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; HL60; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 2924_UP | |
| Drug | Oxethazaine [126-27-2]; Up 200; 8.6uM; HL60; HG-U133A | 1.98e-03 | 195 | 8 | 2 | 1984_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 5569_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 5582_UP | |
| Drug | Vidarabine [5536-17-4]; Up 200; 15uM; HL60; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 2706_UP | |
| Drug | Suxibuzone [27470-51-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 6065_DN | |
| Drug | Probucol [23288-49-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 5261_DN | |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 4421_UP | |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 4407_UP | |
| Drug | Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 4420_UP | |
| Drug | Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3524_UP | |
| Drug | Bezafibrate [41859-67-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 2630_UP | |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3926_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6105_DN | |
| Drug | Azathymine, 6 [932-53-6]; Up 200; 31.4uM; HL60; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 2466_UP | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3525_UP | |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3616_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 1uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3632_UP | |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3627_UP | |
| Drug | Aminohippuric acid [61-78-9]; Up 200; 20.6uM; HL60; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3076_UP | |
| Drug | Aconitine [302-27-2]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6797_UP | |
| Drug | radicicol; Up 200; 0.1uM; PC3; HG-U133A | 2.02e-03 | 197 | 8 | 2 | 484_UP | |
| Drug | Orlistat; Down 200; 10uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6383_DN | |
| Drug | Podophyllotoxin [518-28-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6103_DN | |
| Drug | radicicol; Down 200; 0.1uM; PC3; HG-U133A | 2.02e-03 | 197 | 8 | 2 | 449_DN | |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 5431_UP | |
| Drug | Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; HL60; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 2552_UP | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 6226_UP | |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; PC3; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 5059_UP | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 6976_UP | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 4413_UP | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; HL60; HG-U133A | 2.04e-03 | 198 | 8 | 2 | 1985_UP | |
| Drug | estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 5905_UP | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; PC3; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 6645_UP | |
| Disease | obesity (is_implicated_in) | 9.84e-07 | 91 | 7 | 3 | DOID:9970 (is_implicated_in) | |
| Disease | Mood Disorders | 6.24e-06 | 168 | 7 | 3 | C0525045 | |
| Disease | Calcium channel blocker use measurement | 1.27e-05 | 213 | 7 | 3 | EFO_0009930 | |
| Disease | comparative body size at age 10, self-reported | 9.60e-05 | 420 | 7 | 3 | EFO_0009819 | |
| Disease | mean arterial pressure | 1.60e-04 | 499 | 7 | 3 | EFO_0006340 | |
| Disease | Beta blocking agent use measurement | 3.07e-04 | 114 | 7 | 2 | EFO_0009929 | |
| Disease | sugar consumption measurement | 3.40e-04 | 120 | 7 | 2 | EFO_0010158 | |
| Disease | hypertension (is_implicated_in) | 3.46e-04 | 121 | 7 | 2 | DOID:10763 (is_implicated_in) | |
| Disease | smoking behavior, body mass index | 3.57e-04 | 123 | 7 | 2 | EFO_0004318, EFO_0004340 | |
| Disease | type 2 diabetes mellitus (is_marker_for) | 4.36e-04 | 136 | 7 | 2 | DOID:9352 (is_marker_for) | |
| Disease | Sclerocystic Ovaries | 4.89e-04 | 144 | 7 | 2 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 4.89e-04 | 144 | 7 | 2 | C0032460 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 5.09e-04 | 147 | 7 | 2 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Diuretic use measurement | 6.72e-04 | 169 | 7 | 2 | EFO_0009928 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 6.88e-04 | 171 | 7 | 2 | DOID:9352 (is_implicated_in) | |
| Disease | serum urea measurement | 8.93e-04 | 195 | 7 | 2 | EFO_0009795 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RWLREQQHRRWRLHC | 336 | Q6UB35 | |
| QRQQWRRPRLRRLHQ | 221 | Q9UKP4 | |
| LHSLCQRRALRQWRH | 21 | P46199 | |
| QNLRREWHARCQSRI | 446 | Q9C0B1 | |
| QVRRSIRCLRNIIHW | 171 | P34998 | |
| RSCQLRQHRRQSRPW | 71 | O43812 | |
| RRWNRFNRRRCRAAV | 506 | Q01668 | |
| HRLCLARIQNRRWQR | 211 | Q8WVZ7 | |
| SGCLRWFQHRRNRRR | 586 | Q5JWF2 |